Funding for this research was provided by:
Robert E. Leet and Clara Guthrie Patterson Trust (Mentored Clinical Research Award)
National Institute on Drug Abuse (R25DA033211-07)
U.S. Department of Veterans Affairs (MIRECC VISN-1)
Article History
Accepted: 22 March 2021
First Online: 5 April 2021
Declarations
:
: JPD is supported by the VISN-1 VA Mental Illness, Research, and Education Clinical Center (MIRECC), the Robert E. Leet and Clara Guthrie Patterson Trust, and the National Institute of Drug Abuse (R25DA033211-07).
: The authors have no conflicts of interest to report.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: J.P.D. and M.S. were responsible for the concept and design of the review. J.P.D. and S.P. performed independent review of the clinical reports. MS assisted with interpretation of findings. J.P.D. and M.S. drafted the manuscript. S.P. provided critical revision of the manuscript with important intellectual content. All authors critically reviewed content and approved the final version for publication.
Free to read: This content has been made available to all.